Insiders · EDSA

EDSA insider transactions

Edesa Biotech Inc. (EDSA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for EDSA

• 6d
  Chief Executive Officer Nijhawan Pardeep was granted 1,671 shares, increasing direct ownership by 0.23% to 731,134 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Director Marshall Patrick was granted 19,000 shares, increasing direct ownership by 36% to 71,666 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Director Macdonald Sean Arthur was granted 19,000 shares, increasing direct ownership by 86% to 41,054 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Director Chypyha Joan was granted 19,000 shares, increasing direct ownership by 172% to 30,029 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Chief Financial Officer Weiler Peter J. was granted 64,609 shares, increasing direct ownership by 99% to 129,609 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  President Brooks Michael J was granted 64,609 shares, increasing direct ownership by 28% to 291,479 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Director Sistilli Carlo was granted 19,000 shares, increasing direct ownership by 62% to 49,417 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Director Olson Charles V was granted 19,000 shares, increasing direct ownership by 173% to 30,000 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Chief Executive Officer Nijhawan Pardeep was granted 96,913 shares, increasing direct ownership by 15% to 729,463 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 9d
  Director Liu Da David was granted 19,000 shares, increasing direct ownership by 345% to 24,501 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 37d
  Chief Executive Officer Nijhawan Pardeep was granted 1,159 shares, increasing direct ownership by 0.18% to 632,550 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 58d
  SEC Form 4 filed by Nijhawan Pardeep

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 88d
  SEC Form 4 filed by Edesa Biotech Inc.

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 89d
  Chief Executive Officer Nijhawan Pardeep bought $6,599 worth of shares (1,000 units at $6.60), increasing direct ownership by 0.16% to 628,813 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 93d
  Chief Executive Officer Nijhawan Pardeep bought $39,000 worth of shares (10,000 units at $3.90) (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 94d
  Chief Executive Officer Nijhawan Pardeep bought $42,560 worth of shares (10,000 units at $4.26) (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 95d
  Chief Executive Officer Nijhawan Pardeep bought $36,300 worth of shares (10,000 units at $3.63) (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 96d
  Chief Executive Officer Nijhawan Pardeep bought $6,280 worth of shares (3,000 units at $2.09), increasing direct ownership by 0.32% to 627,813 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 97d
  Chief Executive Officer Nijhawan Pardeep bought $99,176 worth of shares (50,571 units at $1.96) and was granted 10,016 shares, increasing direct ownership by 5% to 625,813 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 97d
  Chief Executive Officer Nijhawan Pardeep was granted 82,236 shares, increasing direct ownership by 16% to 595,226 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 125d
  Chief Executive Officer Nijhawan Pardeep was granted 11,168 shares, increasing direct ownership by 2% to 512,990 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 153d
  Chief Executive Officer Nijhawan Pardeep was granted 10,444 shares, increasing direct ownership by 2% to 501,822 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 187d
  Chief Executive Officer Nijhawan Pardeep was granted 8,766 shares, increasing direct ownership by 2% to 491,378 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 213d
  Chief Executive Officer Nijhawan Pardeep was granted 6,968 shares, increasing direct ownership by 1% to 482,612 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 247d
  Chief Executive Officer Nijhawan Pardeep was granted 5,908 shares, increasing direct ownership by 1% to 475,644 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 268d
  Chief Executive Officer Nijhawan Pardeep was granted 5,981 shares, increasing direct ownership by 1% to 469,736 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 307d
  Chief Executive Officer Nijhawan Pardeep was granted 6,802 shares, increasing direct ownership by 1% to 463,755 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 340d
  Chief Executive Officer Nijhawan Pardeep was granted 7,186 shares, increasing direct ownership by 2% to 456,953 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Director Marshall Patrick was granted 11,000 shares, increasing direct ownership by 26% to 52,666 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Director Olson Charles V was granted 11,000 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Director Sistilli Carlo was granted 20,001 shares, increasing direct ownership by 192% to 30,417 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Chief Executive Officer Nijhawan Pardeep was granted 270,844 shares, increasing direct ownership by 151% to 449,767 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Director Macdonald Sean Arthur was granted 20,001 shares, increasing direct ownership by 974% to 22,054 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Director Chypyha Joan was granted 11,000 shares, increasing direct ownership by 37,931% to 11,029 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  President Brooks Michael J was granted 207,201 shares, increasing direct ownership by 1,173% to 224,870 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Chief Financial Officer Weiler Peter J. was granted 65,000 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 370d
  Director Liu Da David was granted 5,501 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 397d
  Chief Executive Officer Nijhawan Pardeep was granted 6,392 shares, increasing direct ownership by 4% to 178,923 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 401d
  SEC Form 3 filed by new insider Weiler Peter J.

  3 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 430d
  Chief Executive Officer Nijhawan Pardeep was granted 5,784 shares, increasing direct ownership by 3% to 172,531 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 461d
  Chief Executive Officer Nijhawan Pardeep was granted 6,339 shares, increasing direct ownership by 4% to 166,747 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 474d
  New insider Liu Da David claimed no ownership of stock in the company (SEC Form 3)

  3 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 478d
  Director Sistilli Carlo was granted 10,416 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 478d
  SEC Form 4 filed by Chief Executive Officer Nijhawan Pardeep

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 478d
  Director Marshall Patrick was granted 41,666 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 488d
  Chief Executive Officer Nijhawan Pardeep was granted 8,264 shares, increasing direct ownership by 5% to 160,408 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 517d
  Chief Executive Officer Nijhawan Pardeep was granted 8,476 shares, increasing direct ownership by 6% to 152,144 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 551d
  Chief Executive Officer Nijhawan Pardeep was granted 6,420 shares, increasing direct ownership by 5% to 143,668 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 572d
  Chief Executive Officer Nijhawan Pardeep was granted 4,630 shares, increasing direct ownership by 3% to 137,248 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 583d
  SEC Form 4 filed by Chief Executive Officer Nijhawan Pardeep

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 613d
  Chief Executive Officer Nijhawan Pardeep was granted 3,300 shares, increasing direct ownership by 3% to 132,618 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 642d
  Chief Executive Officer Nijhawan Pardeep was granted 3,055 shares, increasing direct ownership by 2% to 129,318 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 674d
  Chief Executive Officer Nijhawan Pardeep was granted 3,317 shares, increasing direct ownership by 3% to 126,263 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 704d
  Chief Executive Officer Nijhawan Pardeep was granted 4,015 shares, increasing direct ownership by 3% to 122,946 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 733d
  Nijhawan Pardeep was granted 4,785 shares, increasing direct ownership by 4% to 118,931 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 767d
  Nijhawan Pardeep was granted 3,083 units of Common Share, increasing direct ownership by 3% to 114,146 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 796d
  Nijhawan Pardeep was granted 3,253 shares, increasing direct ownership by 3% to 111,063 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 804d
  Nijhawan Pardeep bought $20,000 worth of shares (5,000 units at $4.00) (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 828d
  Nijhawan Pardeep was granted 2,765 shares, increasing direct ownership by 3% to 107,810 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 856d
  Nijhawan Pardeep was granted 2,978 shares, increasing direct ownership by 3% to 105,045 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)